EVOLOCUMAB
20190184
Approved small_molecule active
Quick answer
EVOLOCUMAB for Dyslipidemia is a Approved program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Dyslipidemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- active